The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.

Henrik B T Christesen; Bendt B Jacobsen; Stella Odili; Carol Buettger; Antonio Cuesta-Munoz; Torben Hansen; Klaus Brusgaard; Ornella Massa; Mark A Magnuson; Chiyo Shiota

doi:10.2337/diabetes.51.4.1240

The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.

Identifier:nobleid.org/w1/20260515/F2DC76A2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F2DC76A2.svg?ark=w1%2F20260515%2FF2DC76A2)](https://nobleid.org/work/w1/20260515/F2DC76A2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Henrik B T Christesen

Claim authorship of this work

The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.

Identifier:nobleid.org/w1/20260515/F2DC76A2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F2DC76A2.svg?ark=w1%2F20260515%2FF2DC76A2)](https://nobleid.org/work/w1/20260515/F2DC76A2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Henrik B T Christesen

Claim authorship of this work